Bellevue Group’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-855,293
| Closed | -$23.1M | – | 177 |
|
2024
Q2 | $23.1M | Sell |
855,293
-662,937
| -44% | -$17.9M | 0.38% | 66 |
|
2024
Q1 | $27.8M | Buy |
1,518,230
+82,548
| +6% | +$1.51M | 0.42% | 68 |
|
2023
Q4 | $17.6M | Buy |
1,435,682
+5,120
| +0.4% | +$62.8K | 0.27% | 79 |
|
2023
Q3 | $21.4M | Buy |
1,430,562
+73,799
| +5% | +$1.11M | 0.35% | 72 |
|
2023
Q2 | $44.1M | Buy |
1,356,763
+287,024
| +27% | +$9.33M | 0.63% | 54 |
|
2023
Q1 | $41.9M | Buy |
1,069,739
+57,216
| +6% | +$2.24M | 0.61% | 52 |
|
2022
Q4 | $53.5M | Sell |
1,012,523
-34,833
| -3% | -$1.84M | 0.71% | 44 |
|
2022
Q3 | $47.1M | Buy |
1,047,356
+70
| +0% | +$3.15K | 0.68% | 46 |
|
2022
Q2 | $38.1M | Buy |
1,047,286
+1,719
| +0.2% | +$62.6K | 0.54% | 56 |
|
2022
Q1 | $43.2M | Buy |
1,045,567
+93,134
| +10% | +$3.85M | 0.5% | 63 |
|
2021
Q4 | $40.6M | Buy |
952,433
+170,773
| +22% | +$7.28M | 0.42% | 73 |
|
2021
Q3 | $43M | Sell |
781,660
-512,099
| -40% | -$28.2M | 0.44% | 71 |
|
2021
Q2 | $61.9M | Buy |
1,293,759
+134,835
| +12% | +$6.45M | 0.6% | 55 |
|
2021
Q1 | $58.7M | Buy |
1,158,924
+786,034
| +211% | +$39.8M | 0.62% | 53 |
|
2020
Q4 | $23.5M | Buy |
372,890
+72,271
| +24% | +$4.55M | 0.27% | 92 |
|
2020
Q3 | $20.2M | Buy |
300,619
+55,281
| +23% | +$3.72M | 0.28% | 89 |
|
2020
Q2 | $10.3M | Buy |
245,338
+50,755
| +26% | +$2.13M | 0.15% | 106 |
|
2020
Q1 | $6.13M | Buy |
194,583
+10,687
| +6% | +$336K | 0.12% | 109 |
|
2019
Q4 | $7.43M | Buy |
183,896
+51,942
| +39% | +$2.1M | 0.12% | 104 |
|
2019
Q3 | $4.29M | Buy |
131,954
+5,144
| +4% | +$167K | 0.08% | 114 |
|
2019
Q2 | $6.15M | Buy |
+126,810
| New | +$6.15M | 0.1% | 104 |
|